Health Care Gains Limited By Cyclical Bias - Health Care Roundup

Published: 2026-04-13 17:18:16 ET REPL

Published on 04/13/2026 at 05:18 pm EDT

Health-care companies rose, but not by as much as the broad market, as traders rotated into more cyclical sectors ahead of earnings season.

Revolution Medicines stock surged after the cancer-drug biotechnology company said that its experimental pancreatic-cancer treatment nearly doubled overall patient survival compared with chemotherapy in a late-stage trial.

Shares of Replimune Group slid after the biotechnology company cautioned that it was facing mass layoffs and cutbacks in its manufacturing operations after regulators twice rejected an application for an experimental cancer therapy.

Ideaya Biosciences shares surged after the biotech firm logged promising results from a clinical trial evaluating the efficacy of a combination therapy in patients with eye cancer.

Write to Rob Curran at [email protected]

(END) Dow Jones Newswires

04-13-26 1717ET